Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank67
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Percentile
P67
Within normal range
vs 2Y Ago
-3.4x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$-1.86M+73.1%
2024$-6.91M-1356.7%
2023$550000.00+112.3%
2022$-4.47M+70.7%
2021$-15.27M+38.5%
2020$-24.83M-1101.5%
2019$-2.07M+63.6%
2018$-5.68M-366.8%
2013$2.13M+32.1%
2012$1.61M-